Antigenic differences between neurological and diabetic patients with anti‐glutamic acid decarboxylase antibodies

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Neurology

• Publication date

  2005-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1468-1331.2004.00933.xPMID 15804247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating autoantibodies against central nervous system (CNS) antigens in neurological diseases

  2006cited by this paper
• Diabetes Antibody Standardization Program: first assay proficiency evaluation.

  2003influential reference
• Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

  2001cited by this paper
• Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy

  2000cited by this paper
• Glutamate Decarboxylase and GABA in Pancreatic Islets: Lessons from Knock-Out Mice

  1999cited by this paper
• Prevalence and detection of serious psychiatric disorder in defendants attending court.

  1999cited by this paper
• Stiff-man syndrome and its variants.

  1999cited by this paper
• Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies.

  1998cited by this paper
• Stiff man syndrome, 40 years later

  1998cited by this paper
• Stiff-person syndrome

  1998cited by this paper
• Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity

  1997cited by this paper
• Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia.

  1996influential reference
• Glutamic Acid Decarboxylase – Gene to Antigen to Disease

  1996cited by this paper
• Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.

  1996cited by this paper
• Detection of paraneoplastic anti-neuronal autoantibodies on paraffin-embedded tissues

  1996influential reference
• Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies

  1995cited by this paper
• Disease Sensitivity and Specificity of 52 Assays for Glutamic Acid Decarboxylase Antibodies: The Second International GADAB Workshop

  1995cited by this paper
• Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements.

  1995cited by this paper
• Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope.

  1994cited by this paper
• Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus

  1994cited by this paper
• A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM

  1994cited by this paper
• Detection of GAD65 Antibodies in Diabetes and Other Autoimmune Diseases Using a Simple Radioligand Assay

  1994cited by this paper
• Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy

  1994cited by this paper
• Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.

  1993cited by this paper
• Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome

  1993cited by this paper
• An ELISA for Antibodies to Recombinant Glutamic Acid Decarboxylase in IDDM

  1992cited by this paper
• Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.

  1992cited by this paper
• Distinct cytoplasmic islet cell antibodies with different risks for Type 1 (insulin-dependent) diabetes mellitus

  1992cited by this paper
• gamma-Aminobutyric acid outside the mammalian brain.

  1990cited by this paper
• Affinity distributions of antigen-specific IgG in patients with multiple sclerosis and in patients with viral encephalitis.

  1990cited by this paper
• γ‐Aminobutyric Acid Outside the Mammalian Brain

  1990cited by this paper
• Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

  1990cited by this paper
• Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

  1990cited by this paper
• Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.

  1988influential reference
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper
• Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance

  1979cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Quantitative Assay Using Recombinant Human Islet Glutamic Acid Decarboxylase (GAD65) Shows That 64K Autoantibody Positivity at Onset Predicts Diabetes Type

  year unknowncited by this paper

• Anti‐Glutamic Acid Decarboxylase 65 (GAD65) Antibodies and Neurological Syndromes

  2025cites this paper
• Proposing Bromo-Epi-Androsterone (BEA) for Stiff Person Syndrome (SPS)

  2025cites this paper
• Stiff Person Syndrome and GAD Antibody–Spectrum Disorders

  2024cites this paper
• Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies

  2022cites this paper
• Antibodies to neurofilament light as potential biomarkers in multiple sclerosis

  2021cites this paper
• Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?

  2021cites this paper
• GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions

  2021cites this paper
• Immune-mediated epilepsy with GAD65 antibodies.

  2020cites this paper
• Investigation of glutamate receptors in human pancreatic β-cells and their role in insulin secretion

  2020cites this paper
• The neurological syndromes associated with glutamic acid decarboxylase antibodies.

  2019cites this paper
• Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.

  2018cites this paper
• Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED

  2018cites this paper
• Anti-glutamic Acid Decarboxylase Limbic Encephalitis

  2017cites this paper
• Pediatric Demyelinating Diseases of the Central Nervous System and Their Mimics

  2017cites this paper
• Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review

  2017cites this paper
• Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies

  2016cites this paper
• Type 1 diabetes and GAD65 limbic encephalitis: a case report of a 10-year-old girl

  2016cites this paper
• CLINICAL CASE OF A CHILD WITH TYPE 1 DIABETES MELLITUS AND AUTOIMMUNE ENCEPHALOPATHY

  2015cites this paper
• Paraneoplastic Neurologic Syndromes

  2014cites this paper
• Antinuclear antibodies and glutamic acid decarboxylase antibodies in children with refractory epilepsy

  2013cites this paper
• Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.

  2013cites this paper
• Immunological perspectives of temporal lobe seizures.

  2013cites this paper
• Review article Immunological perspectives of temporal lobe seizures

  2013cites this paper
• Newly-diagnosed pediatric epilepsy is associated with elevated autoantibodies to glutamic acid decarboxylase but not cardiolipin.

  2013cites this paper
• Autoimmune stiff person syndrome and related myelopathies: Understanding of electrophysiological and immunological processes

  2012cites this paper
• The association of anti-glutamic acid decarboxylase antibodies with different neurological findings in childhood.

  2012cites this paper
• Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity

  2011cites this paper
• Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?

  2011influential citation
• Comparison of GAD65 and 67 Immunoreactivity in the Lumbar Spinal Cord Between Young Adult and Aged Dogs

  2011cites this paper
• Stiff person syndrome and cerebellar ataxia associated with glutamic acid decarboxylase antibodies and type 1 diabetes: What is the link between neurological diseases and autoimmunity to the beta cell?

  2010cites this paper
• [Stiff-person syndrome and other neurological disorders associated with anti-GAD antibodies].

  2010cites this paper
• Le syndrome de l’homme raide et autres maladies neurologiques associées aux anticorps anti-GAD

  2010cites this paper
• Consensus statement on dementia education and training in Europe

  2010cites this paper
• Intrathecal Immune Responses in Stiff Person Syndrome and Multiple Sclerosis

  2010cites this paper
• Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy

  2010cites this paper
• Effects of the glutamic acid decarboxylase (GAD) inhibitor semicarbazide and anti-GAD autoantibodies-containing immunoglobulin G on neuronal network activity within the motor cortex

  2010cites this paper
• Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems

  2009cites this paper
• Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies

  2009cites this paper
• Comparison of glutamic acid decarboxylase 67 immunoreactive neurons in the hippocampal CA1 region at various age stages in dogs.

  2008cites this paper
• Comparison of Changes in GAD65 and GAD67 Immunoreactivity and Levels in the Gerbil Main Olfactory Bulb Induced by Transient Ischemia

  2008cites this paper
• Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.

  2008cites this paper
• A pathogenetic model of autism involving Purkinje cell loss through anti-GAD antibodies.

  2008cites this paper
• Transient increases of glutamic acid decarboxylase 67 immunoreactivity and its protein levels in the somatosensory cortex after transient cerebral ischemia in gerbils.

  2008cites this paper
• Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies

  2008cites this paper
• Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

  2008cites this paper
• The putative role of neuropeptide autoantibodies in anorexia nervosa

  2008cites this paper
• GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence

  2008cites this paper
• EFFECTS OF ANTI-GAD ANTIBODIES ASSOCIATED WITH NEUROLOGICAL DISEASES

  2007cites this paper
• Quantification of antineural antibodies in autoimmune neurological disorders

  2007cites this paper
• Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies

  2007cites this paper
• Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases

  2007cites this paper
• Clinical approach to a patient presenting with muscle stiffness.

  2003cites this paper